GH Research plc Alternatives & Competitors

12 companies similar to GH Research plc — Targeting Ultra-Rapid, Durable Remissions In Depression (NASDAQ: GHRS)

Acticor Biotech

To treat the acute phase of ischemic stroke !

18 Post-IPO Equity $49.30M

Paris, France

Biopharma Biotechnology +2

Vistagen

Changing the trajectory of mental health care – One Mind at a Time

58 Post-IPO Equity $154.75M

South San Francisco, Unit...

Biotechnology Pharmaceutical

Candid Therapeutics

Developing innovative therapeutics that can materially improve the lives of patients

46 Acquired $2.37B

San Diego, United States

Biotechnology Pharmaceutical

Hua Medicine

56 Series E $242.40M

Biotechnology Health Care +2

Track all GH Research plc competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Tetherex Pharmaceuticals

Pioneering the future of biotechnology to enhance global health, founded in 2014 and headq...

Series B $53.26M

Biotechnology Health Care +1

Nanogen Pharmaceutical Biotechnology Joint Stock Company

Our main goal is to research and produce safe, efficient, and affordable biotherapeutic pr...

61 Venture round

Vietnam

Biotechnology Pharmaceutical

QATCH Technologies

6 Debt Financing $766.09K

Biotechnology Life Sciences +1

Pharmasset, Inc.

11 Post-IPO Equity $115.70M

Biotechnology Health Care +1

Varnotech

Specializing in creating vaccines, antibodies, and adjuvants since 2019 to fight diseases...

1 Venture round

Biotechnology Pharmaceutical

Emalex Biosciences

Improving people's lives impacted by central nervous system disorders through meaningful s...

54 Series D $300.00M

Chicago, United States

Biopharma Biotechnology +3

Sunshine Biopharma Inc

5 Post-IPO Equity $21.91M

Biopharma Biotechnology

Juventas Cell Therapy Corp.

32 Series C $533.74M

China

Biotechnology Health Care +1

About GH Research plc

GH Research plc (NASDAQ: GHRS) is a clinical-stage biopharmaceutical company founded in 2018 with the slogan "Targeting Ultra-Rapid, Durable Remissions In Depression". The company focuses on transforming the treatment of psychiatric and neurological disorders. GH Research recently secured a significant $125.00M Series...

Taxonomy

Biopharmaceuticals, Neurological Conditions, Psychiatric Conditions, Therapy, Revolutionize, Depression, Ultra-Rapid Remissions, Durable Remissions, Start-up, NASDAQ, GH Research, Investment, Innovation, Research And Development

Frequently Asked Questions

Companies similar to GH Research plc include Acticor Biotech, Vistagen, Candid Therapeutics, Hua Medicine, Tetherex Pharmaceuticals. They work in Biotechnology and Pharmaceutical and share GH Research plc's focus on biopharmaceuticals, research and development and innovation.

Bounce Watch lists 12 companies that share GH Research plc's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches GH Research plc and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

GH Research plc Profile Acticor Biotech Alternatives Vistagen Alternatives Hua Medicine Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at GH Research plc on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.